CA1027863A - Composes therapeutiques - Google Patents

Composes therapeutiques

Info

Publication number
CA1027863A
CA1027863A CA202,294A CA202294A CA1027863A CA 1027863 A CA1027863 A CA 1027863A CA 202294 A CA202294 A CA 202294A CA 1027863 A CA1027863 A CA 1027863A
Authority
CA
Canada
Prior art keywords
therapeutical compositions
therapeutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA202,294A
Other languages
English (en)
Other versions
CA202294S (en
Inventor
Maxim I. Lebeaux
Robert N. Boyes
Herbert J.F. Adams
Murray R. Blair (Jr.)
Helen G. Vassallo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASTRA PHARMACEUTICALS PRODUCTS
Original Assignee
ASTRA PHARMACEUTICALS PRODUCTS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ASTRA PHARMACEUTICALS PRODUCTS filed Critical ASTRA PHARMACEUTICALS PRODUCTS
Application granted granted Critical
Publication of CA1027863A publication Critical patent/CA1027863A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0085—Brain, e.g. brain implants; Spinal cord
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA202,294A 1973-08-14 1974-06-12 Composes therapeutiques Expired CA1027863A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US388147A US3898339A (en) 1973-08-14 1973-08-14 Spinal anesthesia using small amounts of tetrodotoxin or desoxytetrodotoxin

Publications (1)

Publication Number Publication Date
CA1027863A true CA1027863A (fr) 1978-03-14

Family

ID=23532901

Family Applications (1)

Application Number Title Priority Date Filing Date
CA202,294A Expired CA1027863A (fr) 1973-08-14 1974-06-12 Composes therapeutiques

Country Status (14)

Country Link
US (1) US3898339A (fr)
JP (1) JPS5048112A (fr)
AT (1) AT335616B (fr)
BE (1) BE816214A (fr)
CA (1) CA1027863A (fr)
DD (1) DD115035A5 (fr)
DE (1) DE2427732A1 (fr)
ES (1) ES427164A1 (fr)
FR (1) FR2240735B1 (fr)
GB (1) GB1453343A (fr)
IE (1) IE39410B1 (fr)
LU (1) LU70304A1 (fr)
NL (1) NL7407853A (fr)
ZA (1) ZA743765B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0750909B1 (fr) * 1994-03-17 2002-12-11 Nanning Maple Leaf Pharmaceutical Co., Ltd. Application de composes de quinazoline amino-hydrogenes et de leurs derives au sevrage des toxicomanes
CN1051706C (zh) * 1994-03-17 2000-04-26 南宁枫叶药业有限公司 氨基氢化喹唑啉类化合物及其衍生物戒降药物依赖性的新用途
US5585398A (en) * 1994-07-15 1996-12-17 Ernst; Amy A. Topical anesthetic comprising lidocaine, adrenaline, and tetracaine, and its method of use
US5550049A (en) * 1994-11-10 1996-08-27 Merck & Co., Inc Process for identifying para cation channel modulators
US6030974A (en) * 1997-04-02 2000-02-29 The Regents Of The University Of California Method of anesthesia
CN1236773C (zh) * 2000-11-22 2006-01-18 南宁枫叶药业有限公司 用于镇痛、麻醉或治疗药物依赖性的制剂
US20100075992A1 (en) * 2004-09-22 2010-03-25 Laboratorios Del Dr. Esteve S.A. Tetrodotoxin and its derivatives for the treament of peripheral-nervously derived neuropathi pain
EP1931349A4 (fr) * 2005-08-25 2009-08-05 Wex Pharmaceuticals Inc Utilisation de bloqueurs des canaux sodiques pour gerer les douleurs musculo-squelettiques
EP2012774A1 (fr) 2006-03-27 2009-01-14 Wex Pharmaceuticals, Inc Utilisation d'inhibiteurs des canaux sodiques pour traiter la douleur neuropathique consécutive à une chimiothérapie

Also Published As

Publication number Publication date
ZA743765B (en) 1975-06-25
ATA484974A (de) 1976-07-15
FR2240735A1 (fr) 1975-03-14
NL7407853A (nl) 1975-02-18
ES427164A1 (es) 1976-10-01
JPS5048112A (fr) 1975-04-30
BE816214A (fr) 1974-12-12
US3898339A (en) 1975-08-05
IE39410L (en) 1975-02-14
AU6993474A (en) 1975-12-11
DE2427732A1 (de) 1975-02-27
DD115035A5 (fr) 1975-09-12
LU70304A1 (fr) 1976-04-13
AT335616B (de) 1977-03-25
IE39410B1 (en) 1978-09-27
FR2240735B1 (fr) 1978-07-28
GB1453343A (en) 1976-10-20

Similar Documents

Publication Publication Date Title
CA1030871A (fr) Compose pharmaceutique
CA1030859A (fr) Melanges de polyolefines et d'elastomeres
CA1026673A (fr) Composes pharmaceutiques
AU467738B2 (en) Novel insecticidal compositions
AU472529B2 (en) Hot-melt compositions
AU475303B2 (en) Novel cyclopropanecaboxlates
CA1022848A (fr) Produits antiparasitaires
AU467891B2 (en) Novel insecticidal compositions
AU498989B2 (en) Pharmaceutical compositions
CA1032677A (fr) Adhesifs
CA1027863A (fr) Composes therapeutiques
CA1032873A (fr) Shampooings
CA1023273A (fr) Composes pour le traitement de la peau
CA1011252A (en) Dihydrocanadensolide compositions
CA1025685A (fr) Composes antiparasitaires
CA1020945A (en) 2-benzimidazolethiol preparation
AU495749B2 (en) Therapeutic composition
AU477679B2 (en) Pesticidal compositions
AU7611374A (en) Therapeutic composition
AU7277374A (en) Therapeutic composition
AU493221B2 (en) Pharmaceutical compositions
AU492729B2 (en) Pharmaceutical compositions
AU478769B2 (en) Pharmaceutical compositions
AU485568B2 (en) Pharmaceutical compositions
AU494300B2 (en) Pharmaceutical compositions